Royalty Pharma

$41.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.20 (+0.49%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Royalty Pharma and other stocks, options, and ETFs commission-free!

About RPRX

Royalty Pharma Plc provides drug development services. The firm operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies.

CEO
Pablo Gerardo Legorreta
Employees
51
Headquarters
New York, New York
Founded
1996
Market Cap
24.71B
Price-Earnings Ratio
16.29
Dividend Yield
1.11
Average Volume
1.56M
High Today
$41.57
Low Today
$40.46
Open Price
$41.00
Volume
677.01K
52 Week High
$56.50
52 Week Low
$34.80

RPRX Earnings

$0.00
$0.33
$0.66
$0.99
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 12, Pre-Market

You May Also Like

ADDYY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure